Source:http://linkedlifedata.com/resource/pubmed/id/12456935
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
2002-11-28
|
pubmed:abstractText |
Pneumococcal conjugate vaccine (PCV) was first licensed for routine administration to young children in February 2000. The objective of this study was to assess physician perspectives about the use of PCV, to ascertain which children were being given the vaccine soon after licensure, and to determine how the addition of PCV to the schedule of recommended childhood vaccines may affect the timing of other vaccinations.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:author |
pubmed-author:AmbroseSandra JSJ,
pubmed-author:BalterSharonS,
pubmed-author:BarthRichard DRD,
pubmed-author:DunnM KatherineMK,
pubmed-author:EdwardsKathrynK,
pubmed-author:SchafferStanley JSJ,
pubmed-author:SchwartzBenjaminB,
pubmed-author:ShoneLaura PLP,
pubmed-author:SzilagyiPeter GPG,
pubmed-author:WeinbergGeoffrey AGA
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
e68
|
pubmed:dateRevised |
2007-11-14
|
pubmed:articleTitle |
Physician perspectives regarding pneumococcal conjugate vaccine.
|
pubmed:affiliation |
New Vaccine Surveillance Network, Department of Pediatrics, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642, USA. stanley_schaffer@urmc.rochester.edu
|